ImageneBio (IMA) Operating Leases (2021 - 2025)

ImageneBio has disclosed Operating Leases across 5 years of filings, most recently posting $713000.0 for Q4 2025.

• Operating Leases for Q4 2025 came in at $713000.0, up 198.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $713000.0 (up 198.33% YoY), and the FY2025 annual result was $713000.0, up 198.33% from the prior year.
• Operating Leases came in at $713000.0 for Q4 2025 at ImageneBio, down from $1.3 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.0 million in Q3 2023 to a low of $239000.0 in Q4 2024.
• The 5-year median for Operating Leases is $4.5 million (2022), against an average of $4.2 million.
• Across the five-year window, Operating Leases plunged 96.67% in 2024 and surged 198.33% in 2025, its largest moves.
• ImageneBio's Operating Leases stood at $5.1 million in 2021, then fell by 26.25% to $3.8 million in 2022, then surged by 89.6% to $7.2 million in 2023, then slumped by 96.67% to $239000.0 in 2024, then jumped by 198.33% to $713000.0 in 2025.
• The last three Operating Leases figures came in at $713000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.